Back
ProShares Ultra Nasdaq Biotechnology Vs. Lantheus Holdings Industry Stock Comparison
Sell
50
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
64.10
Seasonality Move:
14.04%
Sell
18
LNTH
Lantheus Holdings
Last Price:
91.30
Seasonality Move:
-1.72%
Sell
50
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $64.31. The Score for BIB is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Lantheus Holdings (LNTH)
is a Sell
Is Lantheus Holdings a Buy, Sell or Hold?
- The current Lantheus Holdings [LNTH] share price is $91.13. The Score for LNTH is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- LNTH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $64.31
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIB is experiencing slight buying pressure.
LNTH Stock Price Chart
What is Lantheus Holdings's stock price today?
-
The Lantheus Holdings share price today is $91.13
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LNTH is experiencing slight selling pressure.
BIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 55.47 | Buy |
| Chaikin Money Flow: | 680 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.29 - 64.17) | Buy |
| Bollinger Bands (100): | (60.67 - 66.55) | Buy |
LNTH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.5 | Sell |
| Relative Strength Index (14 RSI): | 29.37 | Sell |
| Chaikin Money Flow: | -2309062 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (104.96 - 114.28) | Sell |
| Bollinger Bands (100): | (91.07 - 114.93) | Sell |
BIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 62.39 | Buy |
| 20-day SMA: | 63.05 | Buy |
| 50-day SMA: | 63.92 | Buy |
| 200-day SMA: | 59.83 | Buy |
| 8-day EMA: | 62.7 | Buy |
| 20-day EMA: | 62.84 | Buy |
| 50-day EMA: | 63.29 | Buy |
| 200-day EMA: | 60.29 | Buy |
LNTH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 108.62 | Sell |
| 20-day SMA: | 110.31 | Sell |
| 50-day SMA: | 107.99 | Sell |
| 200-day SMA: | 84.39 | Buy |
| 8-day EMA: | 107.29 | Sell |
| 20-day EMA: | 108.9 | Sell |
| 50-day EMA: | 107.18 | Sell |
| 200-day EMA: | 91.45 | Sell |
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Lantheus Holdings Earnings Growth & LNTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.80 per share, and an increase next year of $0.43 per share.
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lantheus Holdings Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||